4 Biotech Startups Developing Breakthrough Drug Modalities
In the dynamic world of drug discovery, companies must continually innovate beyond their existing drug portfolios and modalities. Relying solely …
Premium Articles
Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering
The integration of artificial intelligence (AI) in biotech is not just enhancing the efficiency of processes but is also enabling …
A Landscape of AI-discovered Molecules and Target Novelty Analysis
We have recently launched a report, “It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?” where …
How Industry Embraces Organ-on-Chips: A 2024 Status Report
Report highlights: We are currently at an exciting juncture where several big pharmaceutical companies have started adopting such models and …
11 Notable Companies Enabling Decentralized Clinical Trials
The world of clinical trials is undergoing an evolution as the rise of decentralized clinical trials (DCTs) brings about a change …
How AI Empowers Biomarker-Driven Clinical Trials
Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …
These 22 Biotechs Collectively Raised $3.3 Billion in Q1 2024. What Do They Have to Offer?
The biotech industry is experiencing a big wave of investment, similar to the high levels seen between 2020 and 2021. …
Notable Trends and Companies to Follow in Neuroscience
Historically, the approval rate for medicines treating central nervous system (CNS) disorders was low. By 2022, the success rate for …
The Growing Momentum for AI Foundation Models in Biotech and 12 Notable Companies
As artificial intelligence (AI) foundation models grow increasingly capable, they become useful for applications across a wide range of economic …
11 Biopharma Trends to Watch in 2024
2023 has marked a remarkable year of technological advancements in drug discovery and biotechnology. Ironically, the elation from a kaleidoscope …
The Rise of Decentralized Clinical Trials: 10 Companies Pushing the Field Forward
The biotech industry has been witnessing a paradigm shift in recent years as it moves away from traditional clinical trials …
Sam Altman-backed Startup Partners with Microsoft to Enable the AI Infrastructure for Drug Discovery
A new five-year commercial agreement and go-to-market collaboration aims to merge 1910 Genetics' comprehensive computational and biological data with Microsoft’s HPC …